col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


13 Results       Page 1

 [1] 
American Chemical Society: Biomacromolecules
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2026―Jan―22 Engineering Elastin-Like Peptide-Based Nanoparticles displaying Variable Domain of the Heavy Chain of Heavy-Chain-Only Antibodies for SARS-CoV-2 Neutralization Duc H. T. Le, Jenny van Oostrum, Els van de Westerlo, Jianhong Wang, Gijs J. Overheul, Ronald P. van Rij, William P. J. Leenders, Jetta Bijlsma, Ilse Roodink, Jan C. M. van Hest, Wouter P.R. Verdurmen
2 [GO] 2025―Sep―08 Engineering a Coiled-Coil Protein for DARPin Presentation as a Potent SARS-CoV-2 Therapeutic Linh D. Mai, Narayanaiah Cheedarla, Siamalan Krishnathas, Ishmamul H. Sadab, Mikaela A. Gray, Wei Lv, Anshul Dhankher, John D. Roback, Andrew S. Neish, Julie A. Champion
3 [GO] 2025―Jul―07 Controlling the Sulfation Density of Glycosaminoglycan Glycopolymer Mimetics Enables High Antiviral Activity against SARS-CoV-2 and Reduces Anticoagulant Activity Miriam Hoffmann, Lorand Bonda, Ines Fels, Darisuran Anhlan, Eike Hrincius, Derik Hermsen, Stephan Ludwig, Mario Schelhaas, Nicole L. Snyder, Laura Hartmann
4 [GO] 2025―May―07 Structural Basis of SARS-CoV-2 Nsp13-Derived Peptide-Mediated NK Cell Activation Xiaole Xu, Song Luo, Jinxin Liu, Enhao Zhang, Houde Liang, Lili Duan
5 [GO] 2023―Mar―31 Biomimetic SARS-CoV-2 Spike Protein Nanoparticles Alvin Phan, Hugo Avila, J. Andrew MacKay
6 [GO] 2022―Dec―23 Dendrimer-Peptide Conjugates for Effective Blockade of the Interactions between SARS-CoV-2 Spike Protein and Human ACE2 Receptor Woo-jin Jeong, Jiyoon Bu, Philip Mickel, Yanxiao Han, Piper A Rawding, Jianxin Wang, Hanbit Kang, Heejoo Hong, Petr Král, Seungpyo Hong
7 [GO] 2022―Aug―22 Surface Inactivation of Highly Mutated SARS-CoV-2 Variants of Concern: Alpha, Delta, and Omicron Valentin A. Bobrin, Sung-Po R. Chen, Carlos Fitzgerald Grandes Reyes, Tim Smith, Damian F. J. Purcell, Jason Armstrong, Julie L. McAuley, Michael J. Monteiro
8 [GO] 2022―Aug―03 PEDOT:PSS in Solution Form Exhibits Strong Potential in Inhibiting SARS-CoV-2 Infection of the Host Cells by Targeting Viruses and Also the Host Cells Jo-Ning Hung, Di Ngoc Kha Vo, Ha Phan Thanh Ho, Ming-Han Tsai
9 [GO] 2022―Mar―28 Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate Christian Isalomboto Nkanga, Oscar A. Ortega-Rivera, Matthew D. Shin, Miguel A. Moreno-Gonzalez, Nicole F. Steinmetz
10 [GO] 2022―Jan―26 Inhalable SARS-CoV-2 Mimetic Particles Induce Pleiotropic Antigen Presentation Atip Lawanprasert, Andrew W. Simonson, Sarah E. Sumner, McKayla J. Nicol, Sopida Pimcharoen, Girish S. Kirimanjeswara, Scott H. Medina
11 [GO] 2021―Dec―09 Lysine β-Hydroxybutyrylation Improves Stability of COVID-19 Antibody Zihua Li, Yudian Zhang, Meng Han, Haiteng Deng, Fuqing Wu, Gang Liu, Guo-Qiang Chen
12 [GO] 2021―Sep―07 Blending of Designer Synthetic Polymers to a Dual Targeted Nanoformulation for SARS-CoV-2 Associated Kidney Damage Bapurao Surnar, Anuj S. Shah, Subham Guin, Nagesh Kolishetti, Alessia Fornoni, Shanta Dhar
13 [GO] 2021―Feb―05 Virus-Like Particles as Positive Controls for COVID-19 RT-LAMP Diagnostic Assays Soo Khim Chan, Pinyi Du, Caroline Ignacio, Sanjay Mehta, Isabel G. Newton, Nicole F. Steinmetz
 [1] 

13 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec